Sionna Therapeutics has closed its initial public offering, raising $191 million for its pipeline of therapies for cystic ...

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Limb-girdle muscular dystrophy type 2D (LGMD2D/R3) is a rare genetic disorder caused by mutations in the SGCA gene, leading to defective folding and the loss of functional α-sarcoglycan, with ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...